Showing results (1341-1350 of 2,182) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|August 7, 2015
A proposed approach for analyzing post-study therapy effect in survival analysisXiaolong Luo, Mingyu Li, Chengqing Wu, et al.Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.Journal of Biopharmaceutical Statistics|September 19, 2015
Enrollment and Stopping Rules for Managing Toxicity Requiring Long Follow-Up in Phase II Oncology TrialsGuochen Song, Anastasia IvanovaJournal of Biopharmaceutical Statistics|September 23, 2015
Seamless Phase IIa/IIb and enhanced dose-finding adaptive designJiacheng Yuan, Herbert Pang, Tiejun Tong, et al.Journal of Biopharmaceutical Statistics|September 23, 2015
Interim analysis based on the weighted log-rank test for delayed treatment effects under staggered patient entryMizuki Yoshida, Yutaka MatsuyamaJournal of Biopharmaceutical Statistics|December 10, 2015
Skew-t partially linear mixed-effects models for AIDS clinical studiesTao LuJournal of Biopharmaceutical Statistics|November 22, 2017
Using previous trial results to inform hypothesis testing of new interventionsChangyu Shen, Xiaochun LiJournal of Biopharmaceutical Statistics|November 22, 2017
Sample size calculations for blinding assessmentVictoria Landsman, Mark Fillery, Howard Vernon, et al.Journal of Biopharmaceutical Statistics|November 28, 2017
Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Traditional multiplicity problemsGautier Paux, Alex DmitrienkoJournal of Biopharmaceutical Statistics|November 28, 2017
Improving the power to establish clinical similarity in a Phase 3 efficacy trial by incorporating prior evidence of analytical and pharmacokinetic similarityDonglin Zeng, Jean Pan, Kuolung Hu, et al.Pageof 219